Neil S. Belloff

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Mahopac, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Neil S. Belloff
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Neil S. Belloff

Form 4 holding COO, GENERAL COUNSEL &CORP SEC

Eloxx Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
32,699
Estimated value
$23,543
Report date
30 Jul 2021
Price
$0.7200
Ownership
Direct
Form 4 holding COO, GENERAL COUNSEL &CORP SEC

Eloxx Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
9,375
Estimated value
$6,750
Report date
30 Jul 2021
Price
$0.7200
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding General Counsel and Corp Secy

Acorda Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
77,300
Estimated value
Report date
31 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Neil S. Belloff

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .